Scott Schoenhaus

Stock Analyst at Keybanc

(0.95)
# 3,907
Out of 5,172 analysts
139
Total ratings
24.39%
Success rate
-18.18%
Average return

Stocks Rated by Scott Schoenhaus

Progyny
Mar 2, 2026
Maintains: Overweight
Price Target: $32$28
Current: $18.13
Upside: +54.44%
Oddity Tech
Feb 26, 2026
Maintains: Overweight
Price Target: $50$30
Current: $13.37
Upside: +124.38%
LifeStance Health Group
Feb 26, 2026
Maintains: Overweight
Price Target: $8$9
Current: $6.40
Upside: +40.63%
Alight
Feb 19, 2026
Downgrades: Sector Weight
Price Target: n/a
Current: $0.68
Upside: -
Talkspace
Jan 8, 2026
Maintains: Overweight
Price Target: $4$5
Current: $5.14
Upside: -2.72%
Schrödinger
Jan 8, 2026
Maintains: Overweight
Price Target: $28$25
Current: $12.02
Upside: +107.99%
HealthEquity
Jan 8, 2026
Maintains: Overweight
Price Target: $120$125
Current: $81.02
Upside: +54.28%
Hinge Health
Jan 8, 2026
Maintains: Overweight
Price Target: $72$70
Current: $42.48
Upside: +64.78%
Doximity
Jan 8, 2026
Maintains: Overweight
Price Target: $75$60
Current: $24.41
Upside: +145.80%
Certara
Jan 8, 2026
Maintains: Overweight
Price Target: $13$12
Current: $6.15
Upside: +95.12%
Upgrades: Overweight
Price Target: $60
Current: $33.09
Upside: +81.32%
Downgrades: Sector Weight
Price Target: n/a
Current: $184.07
Upside: -
Maintains: Overweight
Price Target: $12$8
Current: $3.90
Upside: +105.13%
Maintains: Overweight
Price Target: $205$225
Current: $200.35
Upside: +12.30%
Maintains: Overweight
Price Target: $35$32
Current: $11.86
Upside: +169.81%
Maintains: Overweight
Price Target: $5$4
Current: $1.23
Upside: +225.20%
Downgrades: Sector Weight
Price Target: n/a
Current: $11.67
Upside: -
Maintains: Overweight
Price Target: $5$10
Current: $3.40
Upside: +194.12%
Maintains: Overweight
Price Target: $5$9
Current: $2.96
Upside: +204.05%
Maintains: Overweight
Price Target: $12$10
Current: $3.25
Upside: +207.69%
Maintains: Overweight
Price Target: $7$6
Current: $2.03
Upside: +195.57%
Initiates: Sector Weight
Price Target: n/a
Current: $5.35
Upside: -
Upgrades: Overweight
Price Target: $180$250
Current: $166.07
Upside: +50.54%